Product
Boceprevir
1 clinical trial
2 indications
Indication
Hepatitis CIndication
ChronicClinical trial
A Randomized, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Genotype 1 Hepatitis C Virus InfectionStatus: Completed, Estimated PCD: 2013-01-20